2 completed, 1 active not recruiting. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Completed 1 |
Follow Cortex: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. Electrographic Flow (EGF) mapping and ablation of EGF-identified sources of Atrial Fibrillation, Electrographic Flow (EGF) mapping (no ablation) - Atrial Fibrillation, Atrial Fibrillation, Persistent | Not applicable | Active not recruiting | Cortex | 400 | 2023-10-23 | 2025-04-13 |
| AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation Electrographic Flow™ (EGF) mapping and ablation - Atrial Fibrillation, Persistent, Atrial Fibrillation | Completed | Ablacon, Inc. | 25 | 2022-09-12 | 2025-04-10 | |
| FLOW-AF: A Study to Evaluate Electrographic Flow™ (EGF) Mapping Technology Electrographic Flow™ guided ablation - Atrial Fibrillation, Persistent | Not applicable | Completed | Cortex | 85 | 2019-09-27 | 2025-04-10 |
Atrial Fibrillation (3) · Arrhythmias, Cardiac (2) · Atrial Flutter (1) · Heart Diseases (1)
Netherlands (3) · Czechia (2) · United States (2) · Belgium (1) · Germany (1) · Poland (1)
Kent Nilsson, MD (2) · Lucas Boersma, Prof. MD. (1) · Petr Neuzil, MD (1) · Stefan Spitzer, MD (1) · Tamas Szili-Torok, MD (1)
PMID 41498861, PMID 42623431, PMID 38842972, PMID 39447813, PMID 39817626